Zavante Targets Resistant Urinary Infections With I.V. Version Of Existing Drug

If approved, Zolyd will be the first intravenous epoxide antibiotic approved in the US, with greater potency than the oral version used first-line. Ex-US, the I.V. formulation has demonstrated a stable resistance profile.